Commentary on case E-5/17 on the duration of registration of a supplementary medicinal product protection certificate.
Posted by Elzaburu
English version «The EFTA Court confirms that an SPC may be granted with a negative duration. Judgment of the EFTA Court of 21 December 2017, Merck (E-5/17)»
Text accessible at: https://www.elzaburu.com/es/area-de-documentacion/anuario-elzaburu
Source: ELZABURU Yearbook of European jurisprudence on industrial and intellectual property, 2017, pp. 57-60
Author/s: María Cadarso Díaz de Entre-Sotos
